Research article · 12 Jun 2025
Conference abstractPublished 2017
Lipid-dendrimer hybrid nanosystems as smart carriers of anti-cancer agents
National University of Singapore, Singapore
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Developing novel nanohybrids of lipids and hyperbranched polymeric structures called dendrimers has been emerged as an attractive approach in the design of smart drug delivery systems for anti-cancer drugs, including both hydrophobic and hydrophilic agents. In this study, we aim to show the ability of such nanohybrid systems in improving the therapeutic activity of encapsulated drugs by controlling drug release that could yield synergistic cancer cell killing effect. Methodology: The nanohybrids were made from PC-based lipids and the PAMAM dendrimers in appropriate mole ratios via a sonication step. Paclitaxel (PTX), gemcitabine (GEM) and cisplatin (CIS) was used in this study. Physical characteristics, including size, zeta potential, drug encapsulation efficacy, and drug release in simulated physiological fluids, were determined. Viability of human ovarian cancer cells post drug treatment was determined by MTT viability assay. The combination index (C.I.) was computed to determine synergistic anti-cancer activity of drug combinations. In vivo therapeutic activity was determined in a human ovarian tumor xenograft model in SCID mice. Findings: The drug-loaded nanohybrids displayed diameters ranging 40-200 nm, depending on the type of dendrimer used. The polydispersity indices reflecting the size distribution were 70%. The potency of PTX could be significantly improved when presented in the nanohybrid system, whereby PTX and PAMAM G4.0 acted synergistically in killing the ovarian cancer cells. Despite a 10-fold lower PTX dose, a 50% increase in the median survival time was observed in mice treated with PTX-loaded nanohybrid system. Sequential release of drug combinations was observed from the nanohybrids, and such release properties resulted in synergistic anti-cancer cell killing, whereby the C.I. was <1.0. Conclusion: The lipid-dendrimer nanohybrid systems could pave way for the development of multifunctional delivery systems for cancer therapy.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gigi N C Chiu”
